Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 62Other hematologic neoplasm 52Myeloid 17Sarcoma 9Plasma cell 6Breast 6Genitourinary 5Classical hematology 5Dermatologic 4Gastrointestinal 2CNS 2Other neoplasm 1Other 1Gynecologic 1

Conditions

Neoplasm Metastasis 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 69Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Methotrexate × Gastrointestinal × Clear all
NCT00952016 2016-10-14

MESH

Royal Marsden NHS Foundation Trust

Phase 2 Terminated
2 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01668680 2015-07-08

Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma

HaEmek Medical Center, Israel

Phase 2 Terminated
80 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡